EMN EASTMAN CHEMICAL CO
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 915389 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.3%
TTM net income YoY-10.3%
TTM EPS YoY-12.4%
Revenue 3-yr CAGR-1.2%
Net income 3-yr CAGR3.4%
Margins
Gross margin20.6%
Operating margin—
Net margin7.2%
FCF margin5.2%
EBITDA margin—
Returns
ROE10.7%
ROA4.3%
ROIC (approx.)—
Asset turnover0.59x
Leverage & solvency
Liabilities / assets59.0%
Debt / equity0.83x
Current ratio1.57x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.36x
Accruals ratio-1.5%
Payout ratio59.0%
Capex / revenue4.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.38B | $2.51B | $2.18B | $1.97B | $2.20B | $2.29B | $2.29B | $2.25B |
| Cost of revenue | $1.85B | $1.95B | $1.75B | $1.64B | $1.77B | $1.78B | $1.72B | $1.69B |
| Gross profit | $532.00M | $560.00M | $431.00M | $338.00M | $433.00M | $506.00M | $567.00M | $554.00M |
| R&D expense | $63.00M | $65.00M | $60.00M | $58.00M | $63.00M | $67.00M | $67.00M | $66.00M |
| SG&A expense | $171.00M | $185.00M | $178.00M | $159.00M | $160.00M | $157.00M | $182.00M | $182.00M |
| Pretax income | $249.00M | $256.00M | $136.00M | $12.00M | $134.00M | $169.00M | $253.00M | $297.00M |
| Income tax | -$4.00M | $72.00M | $29.00M | -$93.00M | $65.00M | $29.00M | $70.00M | -$34.00M |
| Net income | $252.00M | $183.00M | $107.00M | $105.00M | $69.00M | $140.00M | $182.00M | $330.00M |
| EPS (basic) | 2.21 | 1.60 | 0.93 | — | 0.60 | 1.22 | 1.58 | — |
| EPS (diluted) | 2.19 | 1.59 | 0.93 | — | 0.60 | 1.20 | 1.57 | — |
| Dividends declared per share | 0.84 | 0.84 | 0.84 | 0.84 | 0.83 | 0.83 | 0.83 | 0.83 |
| Weighted avg. shares (diluted) | 115.30M | 115.30M | 115.00M | — | 115.40M | 116.20M | 116.50M | — |
| Banking | ||||||||
| Net interest income | -$56.00M | -$55.00M | -$52.00M | -$52.00M | -$54.00M | -$53.00M | -$49.00M | -$52.00M |
| Balance sheet | ||||||||
| Cash & equivalents | $768.00M | $691.00M | $665.00M | $566.00M | $489.00M | $423.00M | $418.00M | $837.00M |
| Receivables | $1.06B | $1.10B | $949.00M | $737.00M | $933.00M | $988.00M | $894.00M | $791.00M |
| Inventory | $2.19B | $2.10B | $2.08B | $1.98B | $1.94B | $2.15B | $2.12B | $1.99B |
| Current assets | $4.37B | $4.25B | $4.06B | $3.65B | $3.79B | $4.02B | $3.90B | $4.10B |
| PP&E, net | $5.65B | $5.69B | $5.69B | $5.73B | $5.75B | $5.75B | $5.64B | $5.62B |
| Goodwill | $3.66B | $3.66B | $3.66B | $3.67B | — | $3.67B | $3.64B | $3.63B |
| Intangibles | $905.00M | $924.00M | $946.00M | $970.00M | $1.01B | $1.03B | $1.02B | $1.03B |
| Total assets | $15.47B | $15.42B | $15.22B | $14.86B | $14.98B | $15.22B | $14.97B | $15.21B |
| Current liabilities | $2.77B | $2.84B | $2.77B | $2.65B | $2.16B | $2.39B | $2.27B | $2.71B |
| Short-term debt | $764.00M | $765.00M | $770.00M | $586.00M | $290.00M | $344.00M | $285.00M | $450.00M |
| Long-term debt | $4.45B | $4.45B | $4.45B | $4.20B | $4.79B | $4.78B | $4.74B | $4.57B |
| Total debt | $5.22B | $5.22B | $5.22B | $4.79B | $5.08B | $5.13B | $5.02B | $5.02B |
| Total liabilities | $9.13B | $9.25B | $9.14B | $8.82B | $9.14B | $9.31B | $9.03B | $9.36B |
| Shareholders' equity | $6.28B | $6.10B | $6.01B | $5.96B | $5.77B | $5.83B | $5.87B | $5.78B |
| Net debt | $4.45B | $4.53B | $4.55B | $4.22B | $4.59B | $4.70B | $4.60B | $4.18B |
| Shares outstanding | — | — | — | 223.94M | — | — | — | 223.59M |
| Cash flow statement | ||||||||
| Operating cash flow | $290.00M | $224.00M | -$137.00M | $502.00M | $402.00M | $233.00M | -$167.00M | $540.00M |
| Capital expenditure | $95.00M | $100.00M | $103.00M | $112.00M | $137.00M | $150.00M | $147.00M | $179.00M |
| Free cash flow | $195.00M | $124.00M | -$240.00M | $390.00M | $265.00M | $83.00M | -$314.00M | $361.00M |
| Investing cash flow | -$96.00M | -$99.00M | -$104.00M | -$47.00M | -$137.00M | -$147.00M | -$131.00M | -$132.00M |
| Financing cash flow | -$117.00M | -$100.00M | $341.00M | -$382.00M | -$201.00M | -$90.00M | -$124.00M | -$181.00M |
| Depreciation & amortization | $134.00M | $132.00M | $131.00M | $131.00M | $129.00M | $127.00M | $126.00M | $129.00M |
| Stock-based compensation | $16.00M | $19.00M | $27.00M | $10.00M | $13.00M | $2.00M | $23.00M | $14.00M |
| Dividends paid | $96.00M | $96.00M | $96.00M | $94.00M | $96.00M | $95.00M | $96.00M | $94.00M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.